Arrowhead Pharmaceuticals
3 clinical trials · 3 recruiting · INDUSTRY
Trials by Arrowhead Pharmaceuticals
RECRUITINGPhase 1 / Phase 2NCT07221344
Study of ARO-MAPT-SC in Healthy Subjects and Subjects With Early Alzheimer's Disease
Study to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics of ARO-MAPT-SC compared to placebo in adult healthy volunteers and in participants with...
Sponsor: Arrowhead PharmaceuticalsEnrolling: 1121 location
Alzheimer DiseaseAlzheimer Disease, Early Onset
RECRUITINGPhase 3NCT06822790
Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia
This is an open-label study to be conducted in adults with hypertriglyceridemia (HTG) and severe hypertriglyceridemia (SHTG). Each participant must have completed all required...
Sponsor: Arrowhead PharmaceuticalsEnrolling: 86920 locations
Hypertriglyceridemia
RECRUITINGPhase 1 / Phase 2NCT07223658
Study of ARO-DIMERPA in Adult Participants With Mixed Hyperlipidemia
Study to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD), and effects on low-density lipoprotein cholesterol (LDL-C) and triglycerides (TGs) of...
Sponsor: Arrowhead PharmaceuticalsEnrolling: 781 location
Hyperlipidemia; Mixed